Press Releases
Press Releases
-
Rezolute Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results and Highlights Recent Company Progress
-
Rezolute Announces Initiation of Dosing in the Second Cohort of its Phase 2b Trial of RZ358 for Congenital Hyperinsulinism
-
Rezolute to Participate in Upcoming Virtual Healthcare Conferences
-
Rezolute Announces Initiation of Multiple-Ascending Dose Study of RZ402, Rezolute’s Oral PKI for Treatment of DME
-
Rezolute to Participate in Upcoming Virtual Healthcare Conferences
-
Rezolute Added to Russell Microcap® Index
-
Rezolute to Participate in Upcoming Virtual Healthcare Conferences
-
Rezolute Expands Leadership Team with the Appointment of Davelyn Hood, MD as Director, Scientific and Patient Affairs
-
Rezolute Appoints Leading Ophthalmology Expert, Quan Dong Nguyen, MD, MSc, FAAO, FARVO, to Scientific Advisory Board
-
Rezolute Reports Third Quarter Fiscal 2021 Financial Results and Highlights Recent Company Progress
